Effects of poly (ADP-ribose) polymerase inhibitor 3-aminobenzamide on blood-brain barrier and dopaminergic neurons of rats with lipopolysaccharide- induced Parkinson's disease

Journal of Molecular Neuroscience

Volumn 53, Issue 1, 2014, Pages 1-9

  Wu, Xiao Li ^a   Wang, Ping ^a   Liu, Yun Hui ^a   Xue, Yi Xue ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

3 AB; Blood brain barrier; Neuron; Parkinson's disease; Protection; Tight junction associated protein

Indexed keywords

3 AMINOBENZAMIDE; CLAUDIN 5; EVANS BLUE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; OCCLUDIN; PROTEIN ZO1; TUMOR NECROSIS FACTOR ALPHA; TYROSINE 3 MONOOXYGENASE; 3-AMINOBENZAMIDE; BENZAMIDE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROPROTECTIVE AGENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;

ADULT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN PROTECTION; CELL COUNT; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; MALE; MODULATION; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NONHUMAN; PARKINSON DISEASE; PROTEIN EXPRESSION; RAT; SUBSTANTIA NIGRA; TIGHT JUNCTION; UPREGULATION; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; GENETICS; METABOLISM; TOXICITY; WISTAR RAT;

RATTUS;

ANIMALS; BENZAMIDES; BLOOD-BRAIN BARRIER; CLAUDIN-5; DOPAMINERGIC NEURONS; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEUROPROTECTIVE AGENTS; OCCLUDIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PARKINSON DISEASE; POLY(ADP-RIBOSE) POLYMERASES; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE 3-MONOOXYGENASE; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84899936278     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-013-0175-5     Document Type: Article

References (28)

1. Carvey PM, Zhao CH, Hendey B, Lum H, Trachtenberg J,Desai BS, Snyder J, Zhu YG, Ling ZD (2005) 6-Hydroxydopamine-induced alterations in blood-brain barrier permeability. Eur J Neurosci 22(5):1158-1168 (Pubitemid 41395380)
2. Castaño A, Herrera AJ, Cano J, Machado A (1998) Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system. J neurochem 70(4):1584-1592 (Pubitemid 28136972)
3. Chen X, Lan X, Roche I, Liu R, Geiger JD (2008) Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum. J Neurochem 107(4):1147-1157
4. Cohen-ArmonM, Visochek L, Rozensal D, Kalal A, Geistrikh I, Klein R, Bendetz-Nezer S, Yao Z, Seger R (2007) DNA-independent PARP-1 activation by phosphorylated ERK2 increases Elk1 activity: a link to histone acetylation. Mol Cell 25(2):297-308 (Pubitemid 46127778)
5. D'Amours D, Desnoyers S, D'Silva I, Poirier GG (1999) Poly(ADP-ribosyl) ation reactions in the regulation of nuclear functions. Biochem J 342(Pt 2):249-268 (Pubitemid 29425344)
6. Feng D, Ling WH, Duan RD (2010) Lycopene suppresses LPS-induced NO and IL-6 production by inhibiting the activation of ERK, p38MAPK, and NF-kappaB in macrophages. Inflamm Res 59(2):115-121
7. Hassa PO, Haenni SS, Elser M, Hottiger MO (2006) Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going? Microbiol Mol Biol Rev 70(3):789-829 (Pubitemid 44484693)
8. Kim WG, Mohney RP, Wilson B, Jeohn GH, Liu B, Hong JS (2000) Regional difference in susceptibility to lipopolysacchride-induced neurotoxicity in the rat brain: role of microglia. J Neurosci 20(16):6309-6316 (Pubitemid 30658427)
9. Kim MY, Zhang T, Kraus WL (2005) Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD+into a nuclear signal. Genes Dev 19(17):1951-1967
10. Koh SH, Park Y, Song CW, Kim JG, Kim K, Kim J, Kim MH, Lee SR, Kim DW, Yu HJ, Chang DI, Hwang SJ, Kim SH (2004) The effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signals. Eur J Neurosci 20(6):1461-1472 (Pubitemid 39274030)
11. Kortekaas R, Leenders KL, van Oostrom JC, Vaalburg W, Bart J, Willemsen AT, Hendrikse NH (2005) Blood- brain barrier dysfunction in parkinsonian midbrain in vivo. Ann Neurol 57(2):176-179 (Pubitemid 40179854)
12. Lee HS, Ryu DS, Lee GS, Lee DS (2012) Anti-inflammatory effects of dichloromethane fraction from Orostachys japonicus in RAW264.7 cells: suppression of NF-κB activation and MAPK signaling. J Ethnopharmacol 140(2):271-276
13. Lenzsér G, Kis B, Snipes JA, Gáspár T, Sándor P, Komjáti K, Szabó C, BusijaDW(2007) Contribution of poly(ADP-ribose) polymerase to postischemic blood-brain barrier damage in rats. J Cereb Blood Flow Metab 27(7):1318-1326 (Pubitemid 46985348)
14. Lescot T, Fulla-Oller L, Palmier B, Po C, Beziaud T, Puybasset L, Plotkine M, Gillet B, Meric P, Marchand-Leroux C (2010) Effect of acute poly(ADP-ribose) polymerase inhibition by 3-AB on blood - brain barrier permeability and edema formation after focal traumatic brain injury in rats. J Neurotrauma 27(6):1069-1079
15. McGeer PL, Itagaki S, McGeer EG (1988) Expression of the histocompatibility glycoprotein HLA-DR in neurological disease. Acta Neuropathol 76(6):550-557
16. Moroni F (2008) Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic rain damage. Curr Opin Pharmacol 8(1):96-103
17. Mota RA, Sánchez-Bueno F, Saenz L, Hernández-Espinosa D, Jimeno J, Tornel PL, Martínez-Torrano A, Ramírez P, Parrilla P, Yélamos J (2005) Inhibition of poly(ADP-ri-bose) polymerase attenuates the severity of acute pancreatitis and associated lung injury. Lab Investn 85(10):1250-1262 (Pubitemid 41348640)
18. Qin L, Liu Y, Wang T, Wei SJ, Block ML, Wilson B, Liu B, Hong JS (2004) NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. J Biol Chem 279(2):1415-1421 (Pubitemid 38082669)
19. Rite I, Machado A, Cano J, Venero JL (2007) Blood-brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons. J Neurochem 101(6):1567-1582 (Pubitemid 46848862)
20. Scott GS, Kean RB,Mikheeva T, Fabis MJ,Mabley JG, Szabó C, Hooper DC (2004) The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2- yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation. J Pharmacol Exp Ther 310(3):1053-1061 (Pubitemid 39108927)
21. Singh AK, Jiang Y, Gupta S (2007a) Effects of bacterial toxins on endothelial tight junction in vitro: a mechanism-based investigation. Toxicol Mech Methods 17(6):331-347 (Pubitemid 47124022)
22. Singh AK, Jiang Y, Gupta S, Benlhabib E (2007b) Effects of chronic ethanol drinking on the blood brain barrier and ensuing neuronal toxicity in alcohol-preferring rats subjected to intraperitoneal LPS injection. Alcohol Alcohol 42(5):385-399 (Pubitemid 47604043)
23. Tansey MG, McCoy MK, Frank-Cannon TC (2007) Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention. Exp Neurol 208(1):1-25 (Pubitemid 47603240)
24. Veres B, Radnai B, Gallyas F Jr, Varbiro G, Berente Z, Osz E, Sumegi B (2004) Regulation of kinase cascades and transcription factors by a poly(ADP-ribose) polymerase-1 inhibitor, 4-hydroxyquinazoline, in lipopolysaccharide-induced inflammation in mice. J Pharmacol Exp Ther 310(1):247-255 (Pubitemid 38812718)
25. Whitton PS (2007) Inflammation as a causative factor in the aetiology of Parkinson's disease. Br J Pharmacol 150(8):963-976
26. Wu TT, Chen TL, Loon WS, Tai YT, Cherng YG, Chen RM (2011) Lipopolysaccharide stimulates syntheses of toll-like receptor 2 and surfactant protein-A in human alveolar epithelial A549 cells through upregulating phosphorylation of MEK1 and ERK1/2 and sequential activation of NF-κB. Cytokine 55(1):40-47
27. Yokoyama H, Kuroiwa H, Tsukada T, Uchida H, Kato H, Araki T (2010) Poly(ADP-ribose) polymerse inhibitor can attenuate the neuronal death after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice. J Neurosci Res 88(7):1522-1536
28. Zhao C, Ling Z, Newman MB, Bhatia A, Carvey PM (2007) TNF-alpha knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice. Neurobiol Dis 26(1):36-46 (Pubitemid 46437443)